Annual revenue:
$16.54B+$699.00M(+4.41%)Summary
- As of today (April 18, 2025), TEVA annual revenue is $16.54 billion, with the most recent change of +$699.00 million (+4.41%) on December 31, 2024.
- During the last 3 years, TEVA annual revenue has risen by +$665.00 million (+4.19%).
- TEVA annual revenue is now -24.47% below its all-time high of $21.90 billion, reached on December 31, 2016.
Performance
TEVA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$4.23B-$102.00M(-2.36%)Summary
- As of today (April 18, 2025), TEVA quarterly revenue is $4.23 billion, with the most recent change of -$102.00 million (-2.36%) on December 31, 2024.
- Over the past year, TEVA quarterly revenue has increased by +$410.00 million (+10.74%).
- TEVA quarterly revenue is now -34.86% below its all-time high of $6.49 billion, reached on December 31, 2016.
Performance
TEVA Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$16.54B-$228.00M(-1.36%)Summary
- As of today (April 18, 2025), TEVA TTM revenue is $16.54 billion, with the most recent change of -$228.00 million (-1.36%) on December 31, 2024.
- Over the past year, TEVA TTM revenue has increased by +$540.00 million (+3.37%).
- TEVA TTM revenue is now -29.54% below its all-time high of $23.48 billion, reached on September 30, 2017.
Performance
TEVA TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TEVA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.4% | +10.7% | +3.4% |
| 3 y3 years | +4.2% | +11.7% | +7.2% |
| 5 y5 years | -2.0% | -5.0% | -0.7% |
TEVA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.8% | -5.1% | +17.6% | -1.4% | +10.8% |
| 5 y | 5-year | -2.0% | +10.8% | -5.1% | +17.6% | -3.2% | +10.8% |
| alltime | all time | -24.5% | >+9999.0% | -34.9% | >+9999.0% | -29.5% | >+9999.0% |
Teva Pharmaceutical Industries Limited Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $16.54B(+4.4%) | $4.23B(-2.4%) | $16.54B(-1.4%) |
| Sep 2024 | - | $4.33B(+4.0%) | $16.77B(+3.0%) |
| Jun 2024 | - | $4.16B(+9.0%) | $16.29B(+1.8%) |
| Mar 2024 | - | $3.82B(-14.3%) | $16.00B(+1.0%) |
| Dec 2023 | $15.85B(+6.2%) | $4.46B(+15.8%) | $15.85B(+3.8%) |
| Sep 2023 | - | $3.85B(-0.7%) | $15.27B(+1.7%) |
| Jun 2023 | - | $3.88B(+5.9%) | $15.02B(+0.6%) |
| Mar 2023 | - | $3.66B(-5.7%) | $14.93B(+0.0%) |
| Dec 2022 | $14.93B(-6.0%) | $3.88B(+8.0%) | $14.92B(-1.4%) |
| Sep 2022 | - | $3.60B(-5.0%) | $15.14B(-1.9%) |
| Jun 2022 | - | $3.79B(+3.4%) | $15.43B(-0.8%) |
| Mar 2022 | - | $3.66B(-10.7%) | $15.56B(-2.0%) |
| Dec 2021 | $15.88B(-4.7%) | $4.10B(+5.5%) | $15.88B(-2.2%) |
| Sep 2021 | - | $3.89B(-0.6%) | $16.23B(-0.6%) |
| Jun 2021 | - | $3.91B(-1.8%) | $16.32B(+0.2%) |
| Mar 2021 | - | $3.98B(-10.6%) | $16.28B(-2.3%) |
| Dec 2020 | $16.66B(-1.4%) | $4.45B(+11.9%) | $16.66B(-0.1%) |
| Sep 2020 | - | $3.98B(+2.8%) | $16.67B(-0.7%) |
| Jun 2020 | - | $3.87B(-11.2%) | $16.79B(-1.8%) |
| Mar 2020 | - | $4.36B(-2.5%) | $17.09B(+1.2%) |
| Dec 2019 | $16.89B(-7.6%) | $4.47B(+9.1%) | $16.88B(+3.0%) |
| Sep 2019 | - | $4.09B(-2.0%) | $16.39B(-2.6%) |
| Jun 2019 | - | $4.18B(+0.7%) | $16.83B(-3.0%) |
| Mar 2019 | - | $4.15B(+4.3%) | $17.35B(-5.0%) |
| Dec 2018 | $18.27B(-16.4%) | $3.98B(-12.2%) | $18.27B(-4.6%) |
| Sep 2018 | - | $4.53B(-3.7%) | $19.16B(-5.4%) |
| Jun 2018 | - | $4.70B(-7.2%) | $20.25B(-4.8%) |
| Mar 2018 | - | $5.07B(+4.1%) | $21.27B(-2.7%) |
| Dec 2017 | $21.85B(-0.2%) | $4.87B(-13.4%) | $21.85B(-6.9%) |
| Sep 2017 | - | $5.62B(-1.8%) | $23.48B(+0.2%) |
| Jun 2017 | - | $5.72B(+1.2%) | $23.43B(+3.0%) |
| Mar 2017 | - | $5.65B(-13.0%) | $22.74B(+3.8%) |
| Dec 2016 | $21.90B(+11.5%) | $6.49B(+16.7%) | $21.90B(+7.9%) |
| Sep 2016 | - | $5.56B(+10.4%) | $20.29B(+3.8%) |
| Jun 2016 | - | $5.04B(+4.7%) | $19.55B(+0.4%) |
| Mar 2016 | - | $4.81B(-1.5%) | $19.48B(-0.9%) |
| Dec 2015 | $19.65B(-3.1%) | $4.88B(+1.2%) | $19.65B(-1.4%) |
| Sep 2015 | - | $4.82B(-2.9%) | $19.94B(-1.2%) |
| Jun 2015 | - | $4.97B(-0.3%) | $20.17B(-0.4%) |
| Mar 2015 | - | $4.98B(-3.6%) | $20.25B(-0.1%) |
| Dec 2014 | $20.27B(-0.2%) | $5.17B(+2.2%) | $20.27B(-1.3%) |
| Sep 2014 | - | $5.06B(+0.3%) | $20.53B(-0.0%) |
| Jun 2014 | - | $5.04B(+0.9%) | $20.54B(+0.6%) |
| Mar 2014 | - | $5.00B(-7.9%) | $20.41B(+0.5%) |
| Dec 2013 | $20.31B(-0.0%) | $5.43B(+7.3%) | $20.31B(+0.9%) |
| Sep 2013 | - | $5.06B(+2.7%) | $20.13B(+0.4%) |
| Jun 2013 | - | $4.92B(+0.5%) | $20.05B(-0.3%) |
| Mar 2013 | - | $4.90B(-6.6%) | $20.12B(-1.0%) |
| Dec 2012 | $20.32B(+10.9%) | $5.25B(+5.6%) | $20.32B(-2.1%) |
| Sep 2012 | - | $4.97B(-0.4%) | $20.74B(+3.1%) |
| Jun 2012 | - | $4.99B(-2.1%) | $20.12B(+4.0%) |
| Mar 2012 | - | $5.10B(-10.1%) | $19.33B(+5.6%) |
| Dec 2011 | $18.31B(+13.6%) | $5.68B(+30.7%) | $18.31B(+7.4%) |
| Sep 2011 | - | $4.34B(+3.1%) | $17.05B(+0.6%) |
| Jun 2011 | - | $4.21B(+3.2%) | $16.96B(+2.5%) |
| Mar 2011 | - | $4.08B(-7.7%) | $16.55B(+2.6%) |
| Dec 2010 | $16.12B(+16.0%) | $4.42B(+4.0%) | $16.12B(+4.0%) |
| Sep 2010 | - | $4.25B(+11.8%) | $15.51B(+4.7%) |
| Jun 2010 | - | $3.80B(+4.0%) | $14.80B(+2.8%) |
| Mar 2010 | - | $3.65B(-3.9%) | $14.40B(+3.6%) |
| Dec 2009 | $13.90B(+25.4%) | $3.80B(+7.1%) | $13.90B(+7.4%) |
| Sep 2009 | - | $3.55B(+4.4%) | $12.95B(+5.8%) |
| Jun 2009 | - | $3.40B(+8.0%) | $12.24B(+4.9%) |
| Mar 2009 | - | $3.15B(+10.5%) | $11.66B(+5.2%) |
| Dec 2008 | $11.09B(+17.8%) | $2.85B(+0.2%) | $11.09B(+2.5%) |
| Sep 2008 | - | $2.84B(+0.7%) | $10.81B(+4.6%) |
| Jun 2008 | - | $2.82B(+9.8%) | $10.34B(+4.4%) |
| Mar 2008 | - | $2.57B(-0.2%) | $9.90B(+5.2%) |
| Dec 2007 | $9.41B(+11.9%) | $2.58B(+8.9%) | $9.41B(+3.3%) |
| Sep 2007 | - | $2.37B(-0.8%) | $9.11B(+0.9%) |
| Jun 2007 | - | $2.39B(+14.7%) | $9.03B(+2.4%) |
| Mar 2007 | - | $2.08B(-8.7%) | $8.82B(+4.8%) |
| Dec 2006 | $8.41B(+60.2%) | $2.28B(-0.4%) | $8.41B(+11.6%) |
| Sep 2006 | - | $2.29B(+5.2%) | $7.53B(+14.8%) |
| Jun 2006 | - | $2.17B(+29.9%) | $6.56B(+16.8%) |
| Mar 2006 | - | $1.67B(+19.4%) | $5.62B(+7.0%) |
| Dec 2005 | $5.25B | $1.40B(+6.3%) | $5.25B(+1.5%) |
| Sep 2005 | - | $1.32B(+7.3%) | $5.17B(+1.4%) |
| Jun 2005 | - | $1.23B(-6.0%) | $5.10B(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | $1.30B(-1.4%) | $5.05B(+5.3%) |
| Dec 2004 | $4.80B(+46.5%) | $1.32B(+6.1%) | $4.80B(+8.6%) |
| Sep 2004 | - | $1.25B(+6.0%) | $4.42B(+10.9%) |
| Jun 2004 | - | $1.18B(+11.8%) | $3.98B(+11.5%) |
| Mar 2004 | - | $1.05B(+11.7%) | $3.57B(+9.0%) |
| Dec 2003 | $3.28B(+30.1%) | $942.00M(+15.9%) | $3.28B(+5.5%) |
| Sep 2003 | - | $812.60M(+6.3%) | $3.10B(+6.2%) |
| Jun 2003 | - | $764.40M(+0.9%) | $2.92B(+7.0%) |
| Mar 2003 | - | $757.40M(-1.7%) | $2.73B(+8.4%) |
| Dec 2002 | $2.52B(+21.2%) | $770.20M(+22.0%) | $2.52B(+8.8%) |
| Sep 2002 | - | $631.30M(+10.4%) | $2.32B(+5.7%) |
| Jun 2002 | - | $572.00M(+4.9%) | $2.19B(+2.7%) |
| Mar 2002 | - | $545.10M(-3.9%) | $2.13B(+2.6%) |
| Dec 2001 | $2.08B(+18.7%) | $567.07M(+12.1%) | $2.08B(+2.4%) |
| Sep 2001 | - | $505.70M(-1.5%) | $2.03B(+2.8%) |
| Jun 2001 | - | $513.59M(+4.6%) | $1.97B(+3.7%) |
| Mar 2001 | - | $490.93M(-5.3%) | $1.90B(+8.8%) |
| Dec 2000 | $1.75B(+36.5%) | $518.47M(+15.2%) | $1.75B(+8.6%) |
| Sep 2000 | - | $450.05M(+1.4%) | $1.61B(+8.7%) |
| Jun 2000 | - | $444.00M(+31.6%) | $1.48B(+11.3%) |
| Mar 2000 | - | $337.33M(-11.2%) | $1.33B(+3.9%) |
| Dec 1999 | $1.28B(+14.9%) | $379.90M(+18.3%) | $1.28B(+6.9%) |
| Sep 1999 | - | $321.14M(+9.3%) | $1.20B(+1.5%) |
| Jun 1999 | - | $293.74M(+2.1%) | $1.18B(+4.1%) |
| Mar 1999 | - | $287.62M(-3.1%) | $1.13B(+1.7%) |
| Dec 1998 | $1.12B(-0.1%) | $296.93M(-2.1%) | $1.12B(+0.5%) |
| Sep 1998 | - | $303.30M(+22.7%) | $1.11B(+1.5%) |
| Jun 1998 | - | $247.10M(-8.0%) | $1.09B(-2.1%) |
| Mar 1998 | - | $268.60M(-8.0%) | $1.12B(+0.1%) |
| Dec 1997 | $1.12B(+17.1%) | $291.90M(+1.8%) | $1.12B(+1.3%) |
| Sep 1997 | - | $286.70M(+5.9%) | $1.10B(+4.8%) |
| Jun 1997 | - | $270.70M(+1.2%) | $1.05B(+2.0%) |
| Mar 1997 | - | $267.60M(-3.6%) | $1.03B(+8.2%) |
| Dec 1996 | $953.80M(+17.6%) | $277.70M(+17.4%) | $953.80M(-5.8%) |
| Sep 1996 | - | $236.60M(-5.4%) | $1.01B(+7.6%) |
| Jun 1996 | - | $250.20M(+32.2%) | $941.30M(+11.0%) |
| Mar 1996 | - | $189.30M(-43.7%) | $847.90M(+4.5%) |
| Dec 1995 | $811.30M(+11.4%) | $336.50M(+103.6%) | $811.30M(+4.5%) |
| Sep 1995 | - | $165.30M(+5.4%) | $776.00M(+2.9%) |
| Jun 1995 | - | $156.80M(+2.7%) | $754.20M(+1.3%) |
| Mar 1995 | - | $152.70M(-49.3%) | $744.30M(+2.2%) |
| Dec 1994 | $728.30M(+45.1%) | $301.20M(+109.9%) | $728.30M(+30.4%) |
| Sep 1994 | - | $143.50M(-2.3%) | $558.40M(+3.0%) |
| Jun 1994 | - | $146.90M(+7.5%) | $542.10M(+4.2%) |
| Mar 1994 | - | $136.70M(+4.1%) | $520.20M(+3.6%) |
| Dec 1993 | $502.00M(+26.7%) | $131.30M(+3.2%) | $501.90M(+2.0%) |
| Sep 1993 | - | $127.20M(+1.8%) | $492.10M(+7.5%) |
| Jun 1993 | - | $125.00M(+5.6%) | $457.90M(+7.5%) |
| Mar 1993 | - | $118.40M(-2.6%) | $425.90M(+6.4%) |
| Dec 1992 | $396.30M(+21.2%) | $121.50M(+30.6%) | $400.40M(+10.7%) |
| Sep 1992 | - | $93.00M(0.0%) | $361.60M(+4.1%) |
| Jun 1992 | - | $93.00M(+0.1%) | $347.30M(+4.6%) |
| Mar 1992 | - | $92.90M(+12.3%) | $332.10M(+1.7%) |
| Dec 1991 | $327.10M(-0.6%) | $82.70M(+5.1%) | $326.50M(-14.9%) |
| Sep 1991 | - | $78.70M(+1.2%) | $383.70M(+4.4%) |
| Jun 1991 | - | $77.80M(-10.9%) | $367.60M(+2.3%) |
| Mar 1991 | - | $87.30M(-37.6%) | $359.40M(+6.4%) |
| Dec 1990 | $329.00M(+17.0%) | $139.90M(+123.5%) | $337.80M(+19.3%) |
| Sep 1990 | - | $62.60M(-10.1%) | $283.20M(-0.4%) |
| Jun 1990 | - | $69.60M(+5.9%) | $284.40M(+0.3%) |
| Mar 1990 | - | $65.70M(-23.0%) | $283.60M(-0.9%) |
| Dec 1989 | $281.10M(+33.2%) | $85.30M(+33.7%) | $286.10M(+7.1%) |
| Sep 1989 | - | $63.80M(-7.3%) | $267.20M(+6.9%) |
| Jun 1989 | - | $68.80M(+0.9%) | $250.00M(+8.1%) |
| Mar 1989 | - | $68.20M(+2.7%) | $231.30M(+8.5%) |
| Dec 1988 | $211.10M(+51.2%) | $66.40M(+42.5%) | $213.10M(+45.3%) |
| Sep 1988 | - | $46.60M(-7.0%) | $146.70M(+14.1%) |
| Jun 1988 | - | $50.10M(+0.2%) | $128.60M(+22.6%) |
| Mar 1988 | - | $50.00M(+75.4%) | $104.90M(-15.9%) |
| Sep 1987 | - | $28.50M(+8.0%) | $124.70M(-4.9%) |
| Jun 1987 | - | $26.40M(-24.4%) | $131.10M(-6.1%) |
| Mar 1987 | $139.60M(+53.1%) | $34.90M(0.0%) | $139.60M(+9.5%) |
| Dec 1986 | - | $34.90M(0.0%) | $127.50M(+10.5%) |
| Sep 1986 | - | $34.90M(0.0%) | $115.40M(+11.7%) |
| Jun 1986 | - | $34.90M(+53.1%) | $103.30M(+13.3%) |
| Mar 1986 | $91.20M | $22.80M(0.0%) | $91.20M(+33.3%) |
| Dec 1985 | - | $22.80M(0.0%) | $68.40M(+50.0%) |
| Sep 1985 | - | $22.80M(0.0%) | $45.60M(+100.0%) |
| Jun 1985 | - | $22.80M | $22.80M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual revenue?
- What is the all time high annual revenue for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual revenue year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly revenue?
- What is the all time high quarterly revenue for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly revenue year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM revenue?
- What is the all time high TTM revenue for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM revenue year-on-year change?
What is Teva Pharmaceutical Industries Limited annual revenue?
The current annual revenue of TEVA is $16.54B
What is the all time high annual revenue for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual revenue is $21.90B
What is Teva Pharmaceutical Industries Limited annual revenue year-on-year change?
Over the past year, TEVA annual revenue has changed by +$699.00M (+4.41%)
What is Teva Pharmaceutical Industries Limited quarterly revenue?
The current quarterly revenue of TEVA is $4.23B
What is the all time high quarterly revenue for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly revenue is $6.49B
What is Teva Pharmaceutical Industries Limited quarterly revenue year-on-year change?
Over the past year, TEVA quarterly revenue has changed by +$410.00M (+10.74%)
What is Teva Pharmaceutical Industries Limited TTM revenue?
The current TTM revenue of TEVA is $16.54B
What is the all time high TTM revenue for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM revenue is $23.48B
What is Teva Pharmaceutical Industries Limited TTM revenue year-on-year change?
Over the past year, TEVA TTM revenue has changed by +$540.00M (+3.37%)